Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series-Reference-Cited by-同舟云学术

Breast Cancer Subtypes and Prognosis: Answers to Subgroup Classification Questions, Identifying the Worst Subgroup in Our Single-Center Series

Published:2022-09 Issue: Volume:Volume 14 Page:259-280
ISSN:1179-1314
Container-title:Breast Cancer: Targets and Therapy
language:en
Short-container-title:BCTT

Author:

Cosar Rusen^ORCID,Sut Necdet^ORCID,Ozen Alaattin,Tastekin Ebru,Topaloglu Sernaz,Cicin Irfan,Nurlu Dilek,Ozler Talar,Demir Seda,Yıldız Gokay^ORCID,Şenödeyici Eylül^ORCID,Uzal Mustafa Cem

Publisher

Informa UK Limited

Subject

Oncology

Reference51 articles.

1. Cancer statistics, 2022

2. Ecosystems of invasion and metastasis in mammary morphogenesis and cancer

3. Molecular portraits of human breast tumours

4. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

5. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70. doi:10.1038/nature11412

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review;International Journal of Molecular Sciences;2024-03-13

2. Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells;Saudi Pharmaceutical Journal;2023-12

3. Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort;Frontiers in Oncology;2023-10-24

4. DNA aneuploidy identifies a subset of Luminal subtype breast carcinoma patients with worse clinical outcome;Pathology - Research and Practice;2023-06

5. Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer;Frontiers in Oncology;2023-03-27